Skip to main content
. 2018 Dec 21;9(1):114–127. doi: 10.1039/c8ra07470d

Fig. 2. The glucose level (mmol L−1) changes of 3T3-L1 cells with insulin resistance were treated with chromium malate (5.0, 10.0 and 20.0 μg Cr per mL, low, middle and high dose groups). Chromium trichloride (20.0 μg Cr per mL) and chromium picolinate (20.0 μg Cr per mL) were used as a positive control. Each value was presented as means ± SD (n = 10). aSignificantly different from normal group (p < 0.05); bsignificantly different from model group (p < 0.05); csignificantly different from chromium trichloride group (p < 0.05); dsignificantly different from chromium picolinate group (p < 0.05).

Fig. 2